GoHealth, Inc. (GOCO): Nasdaq/NYSE listing notice — GoHealth receives 180-day Nasdaq extension to May 2023; transfers to Capital Market, executes reverse stock split

GoHealth, Inc.

Nasdaq granted additional 180 days until May 22, 2023 to meet minimum bid price of $1.00.
Transfer from Global Market to Capital Market approved and effective Nov 18, 2022.
Reverse stock split on Nov 17, 2022 brought Class A common stock above $1.00.
To regain compliance, bid price must be at least $1.00 for 10 consecutive business days before May 22, 2023.
Failure to comply by May 22, 2023 could lead to delisting, with appeal rights.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GoHealth, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

November 22, 2022, the Company received a written letter (the “Extension Notice”) from Nasdaq notifying the Company that Nasdaq has granted the Company an additional 180 calendar days, or until May 22, 2023 (the “Extension Period”), to regain compliance with the Minimum Bid Price Requirement. In addition, on November 16, 2022, Nasdaq notified the Company that it had approved the Company’s application to transfer its listing from Nasdaq’s Global Market tier to the Capital Market tier, which was a prerequisite to obtaining the Extension Period. This transfer was effective at the opening of busin

View on SEC.gov

Browse all listing & compliance notices →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001808220-22-000114

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.